companiesandmarkets.com


Cypress Bioscience, Inc - Financial and Strategic Analysis Review

http://www.companiesandmarkets.com/Summary-Company-Profile/cypress-bioscience,-inc-financial-and-strategic-analysis-review-85415.asp


Report Summary

Cypress Bioscience, Inc - Financial and Strategic Analysis Review

Summary

Cypress Bioscience, Inc. (Cypress) is a pharmaceutical company primarily focusing on developing therapeutics for the medical condition Fibromyalgia. The company also provides personalized medicine laboratory services which include Avise MCV and Avise PG for rheumatologists. The company received approval for Savella from the FDA in January 2009 for the management of fibromyalgia, a chronic, debilitating disorder affecting up to 6 million Americans. Cypress and Forest Laboratories, jointly market Savella in the US. The company is headquartered in San Diego, United States

The Cypress Bioscience, Inc - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Cypress Bioscience, Inc. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

- Provides key company information for business intelligence needs.
- The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
- The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
- The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

- A quick "one-stop-shop" to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial and strategic analysis on companies operating in your industry.
- Identify prospective partners and suppliers – with key data on their businesses and locations.
- Capitalize on competitor's weaknesses and target the market opportunities available to them.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

Table of Contents


Table Of Contents
Table Of Contents 2
List of Tables 3
List of Figures 3
Cypress Bioscience, Inc - Key Facts 4
Cypress Bioscience, Inc - Business Description 4
Cypress Bioscience, Inc - Major Products and Services 5
Cypress Bioscience, Inc - History 6
Cypress Bioscience, Inc - SWOT Analysis 7
SWOT Analysis - Overview 7
Cypress Bioscience, Inc - Strengths 7
Strength - Significant Increase in Revenues 7
Strength - FDA's Marketing Approval for Savella 7
Cypress Bioscience, Inc - Weaknesses 7
Weakness - No Revenue from Product Sales 7
Cypress Bioscience, Inc - Opportunities 7
Opportunity - Therapeutic Focus 7
Opportunity - Changing Demographics 8
Opportunity - Rising Healthcare Expenditure in the US 8
Cypress Bioscience, Inc - Threats 8
Threat - Intense Competition 8
Threat - Tightening of FDA’s Regulatory Oversight 8
Threat - Impact of Financial Crisis 8
Threat - Industry Consolidation 8
Cypress Bioscience, Inc - Key Competitors 9
Cypress Bioscience, Inc - Key Employees 9
Cypress Bioscience, Inc - Key Employee Biographies 10
Cypress Bioscience, Inc - Company Statement 11
Cypress Bioscience, Inc - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Cypress Bioscience, Inc - Financial Ratios 14
Financial Ratios - Capital Market Ratios 14
Financial Ratios - Annual Ratios 14
Financial Ratios - Interim Ratios 15
Financial Ratios - Ratio Charts 16
Appendix 17
Methodology 17
Ratio Definitions 17
About Global Markets Direct 20
Contact Us 20
Disclaimer 20


List of Tables
Cypress Bioscience, Inc, Key Facts 4
Cypress Bioscience, Inc, Major Products and Services 5
Cypress Bioscience, Inc, History 6
Cypress Bioscience, Inc, Key Employees 9
Cypress Bioscience, Inc, Key Employee Biographies 10
Cypress Bioscience, Inc, Subsidiaries 13
Cypress Bioscience, Inc, Ratios based on current share price 14
Cypress Bioscience, Inc, Annual Ratios 14
Cypress Bioscience, Inc, Interim Ratios 15
Currency Codes 17
Capital Market Ratios 17
Equity Ratios 18
Profitability Ratios 18
Cost Ratios 18
Liquidity Ratios 19
Leverage Ratios 19
Efficiency Ratios 19


List of Figures
Cypress Bioscience, Inc, Ratio Charts 16